Authors:
Strojan, P
Budinha, M
Smid, L
Svetic, B
Vrhovec, I
Skrk, J
Citation: P. Strojan et al., Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck, NEOPLASMA, 48(1), 2001, pp. 66-71
Authors:
Strojan, P
Budihna, M
Smid, L
Svetic, B
Vrhovec, I
Kos, J
Skrk, J
Citation: P. Strojan et al., Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck, CLIN CANC R, 6(3), 2000, pp. 1052-1062
Authors:
Strojan, P
Budihna, M
Smid, L
Vrhovec, I
Skrk, J
Citation: P. Strojan et al., Urokinase-type plasminogen activator, plasminogen activator inhibitor type1 and cathepsin D: Analysis of their prognostic significance in squamous cell carcinoma of the head and neck, ANTICANC R, 20(5C), 2000, pp. 3975-3981
Citation: M. Cemazar et al., Changed delivery of boron to tumours using electroporation for boron neutron capture therapy with BSH, BR J RADIOL, 73(866), 2000, pp. 195-200
Authors:
Osmak, M
Niksic, D
Brozovic, A
Ristov, AA
Vrhovec, I
Skrk, J
Citation: M. Osmak et al., Drug resistant tumor cells have increased levels of tumor markers for invasion and metastasis, ANTICANC R, 19(4B), 1999, pp. 3193-3197
Citation: M. Osmak et al., Cisplatin resistant glioblastoma cells may have increased concentration ofurokinase plasminogen activator and plasminogen activator inhibitor type 1, J NEURO-ONC, 42(2), 1999, pp. 95-102